Global GERD Market 2016-2020

Table of contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings
• Product profiles

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Disease overview

• Understanding the disease
• Types of GERD
• Signs and symptoms
• Risk factors
• Diagnosis
• Treatment
• Usage of OTC drugs in GERD
• Epidemiology
• Economic burden

PART 06: Pipeline portfolio

• Information on pipeline candidates

PART 07: Market landscape

• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by drug class

PART 09: Global antacids market

• Introduction
• Market overview

PART 10: Global PPI drugs market

• Introduction
• Market overview

PART 11: Global H2 receptor antagonist drugs market

• Introduction
• Market overview

PART 12: Market segmentation by route of administration38

• Oral
• Parenteral

PART 13: Market segmentation by dosage form

• Solid
• Liquid

PART 14: Geographical segmentation

• Global GERD drugs market segmentation by geography
• GERD drugs market in the Americas
• GERD drugs market in EMEA
• GERD drugs market in APAC

PART 15: Market drivers

• Lifestyle factors
• Overuse of medicines and dietary supplements
• Unmet medical needs
• Increase in prevalence of GERD
• Cost-effective OTC drugs

PART 16: Impact of drivers

PART 17: Market challenges

• Increased preference for CAM
• Adverse effects of drugs
• Generic erosion
• Counterfeit drugs

PART 18: Impact of drivers and challenges

PART 19: Market trends

• Self-medication
• Increase in awareness about GERD
• Intense competition
• Strategic alliances

PART 20: Vendor landscape

• Competitive scenario

PART 21: Key vendor analysis

• AstraZeneca
• Eisai
• GSK
• Johnson & Johnson
• Takeda
• Other prominent vendors

PART 22: Appendix

• List of abbreviations

PART 23: Explore Technavio